Laura K. Aguilar

Insider Reports History

Entity
Individual
Location
Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham, MA
Signature
/s/ John Canepa, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura K. Aguilar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. 10%+ Owner Common Stock 2.01M $1.81M $0.90 May 6, 2022 By Laura K. Aguilar 2020 Irrevocable Trust
Candel Therapeutics, Inc. 10%+ Owner Common Stock 1.03M $930K $0.90 May 6, 2022 Direct
Candel Therapeutics, Inc. 10%+ Owner Stock Option (Right to Buy) 0 May 6, 2022 Direct

Insider Reports Filed by Laura K. Aguilar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. May 6, 2022 5 $0 4 May 10, 2022 10%+ Owner
CADL Candel Therapeutics, Inc. Jul 29, 2021 2 $0 4 Aug 2, 2021 Chief Medical Officer
CADL Candel Therapeutics, Inc. Jul 26, 2021 0 $0 3 Jul 26, 2021 Chief Medical Officer